Monica Shaw

Monica Shaw supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurement activities that enable public health preparedness and scientific response. She manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research tools, and data infrastructure essential to disease surveillance and outbreak response. Her work ensures the timely acquisition of advanced analytical instruments, specialized technical services, and logistics support critical to CDC’s operational readiness and global health initiatives. She operates within a high-stakes environment where procurement decisions directly impact national and international public health outcomes. Shaw maintains consistent working relationships with key contractors including General Dynamics Information Technology, GlaxoSmithKline, Cepheid, MRIGLOBAL, and the New York City Health & Hospitals Corp. These partnerships span high-complexity domains such as infectious disease diagnostics, clinical research support, and hazardous material handling. Her contracting approach emphasizes technical rigor, regulatory compliance, and performance-based outcomes, often involving long-term service agreements and delivery orders for mission-critical supplies and systems. She collaborates closely with scientific and operational stakeholders to align procurement with evolving public health priorities. Shaw’s procurement portfolio reflects a strong preference for full and open competition, with 100% of awards issued under no set-aside classifications. This indicates a strategic focus on leveraging broad market capability to meet urgent, technically demanding requirements rather than socioeconomic set-asides. While small business participation is not formally prioritized in her award patterns, she ensures competitive fairness and transparency across all solicitations, adhering strictly to federal acquisition regulations. Her primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing) and 541990 (professional, scientific, and technical services), reflecting deep expertise in procuring next-generation PCR systems, genomic sequencing platforms, epidemiological data analytics tools, and specialized training for public health workforce development. She routinely sources high-precision diagnostic equipment, biosafety-compliant logistics, and hazardous waste management services, demonstrating specialized knowledge in laboratory systems and public health operational infrastructure.